GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Humanwell Healthcare (Group) Co Ltd (SHSE:600079) » Definitions » YoY EPS Growth

Humanwell Healthcare (Group) Co (SHSE:600079) YoY EPS Growth : 10.00% (As of Mar. 2025)


View and export this data going back to 1997. Start your Free Trial

What is Humanwell Healthcare (Group) Co YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Humanwell Healthcare (Group) Co's YoY EPS Growth for the quarter that ended in Mar. 2025 was 10.00%.

Humanwell Healthcare (Group) Co's Earnings per Share (Diluted) for the three months ended in Mar. 2025 was ¥0.33.

Humanwell Healthcare (Group) Co YoY EPS Growth Historical Data

The historical data trend for Humanwell Healthcare (Group) Co's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Humanwell Healthcare (Group) Co YoY EPS Growth Chart

Humanwell Healthcare (Group) Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 25.86 12.33 87.80 -14.94 -37.40

Humanwell Healthcare (Group) Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -26.83 -5.00 7.41 -172.73 10.00

Humanwell Healthcare (Group) Co YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Humanwell Healthcare (Group) Co's YoY EPS Growth for the fiscal year that ended in Dec. 2024 is calculated as:

YoY EPS Growth (A: Dec. 2024 )
=(Earnings per Share (Diluted) (A: Dec. 2024 )-Earnings per Share (Diluted) (A: Dec. 2023 ))/ | Earnings per Share (Diluted) (A: Dec. 2023 ) |
=(0.82-1.31)/ | 1.31 |
=-37.40 %

Humanwell Healthcare (Group) Co's YoY EPS Growth for the quarter that ended in Mar. 2025 is calculated as:

YoY EPS Growth (Q: Mar. 2025 )
=(Earnings per Share (Diluted) (Q: Mar. 2025 )-Earnings per Share (Diluted) (Q: Mar. 2024 )) / | Earnings per Share (Diluted) (Q: Mar. 2024 )) |
=(0.33-0.3)/ | 0.3 |
=10.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Humanwell Healthcare (Group) Co YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Humanwell Healthcare (Group) Co's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Humanwell Healthcare (Group) Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Humanwell Healthcare (Group) Co Ltd (SHSE:600079) » Definitions » YoY EPS Growth
Comparable Companies
SZSE:000423 SZSE:000513 SZSE:002773 SHSE:600518 SZSE:000661 SHSE:600521 SHSE:688192 SHSE:600566 SZSE:002603 SHSE:600535 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
N/A
Address
No.666 Gaoxin Road, East Lake High-tech Development Zone, Hubei, Hubei Province, Wuhan, CHN, 430075
Website
https://www.humanwell.com.cn
Humanwell Healthcare (Group) Co Ltd is a China-based integrated healthcare solution provider. Being a pharmaceutical company, it provides medicinal products including fertility-regulating drugs, Uygur medicine, traditional Chinese medicine, medical devices, over-the-counter medicines, anti-infection drugs, herbal medicines, and biological products. The organization has a business presence in China and other international countries.
Executives
Wang Xue Hai Director
Li Jie Director
Xu Hua Bin senior management
Du Wen Tao senior management
Wu Ya Jun senior management
Deng Xia Fei Directors, senior managers
Li Li E senior management
Yu Qun senior management
Zhang Hong Jie senior management
Yin Qiang senior management
Li Qian Lun senior management
Gai Song Mei Supervisors
Zhang Xiao Dong Director
Liu Yi senior management
Ai Lu Ming Director

Humanwell Healthcare (Group) Co Headlines

No Headlines